We are analyzing https://link.springer.com/article/10.1007/s10741-007-9007-4.

Title:
Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects | Heart Failure Reviews
Description:
Cardiac hypertrophy is promoted by adrenergic over-activation and represents an independent risk factor for cardiovascular morbidity and mortality. The basic knowledge about mechanisms by which sustained adrenergic activation promotes myocardial growth, as well as understanding how structural changes in hypertrophied myocardium could affect myocardial function has been acquired from studies using an animal model of chronic systemic β-adrenoreceptor agonist administration. Sustained β-adrenoreceptor activation was shown to enhance the synthesis of myocardial proteins, an effect mediated via stimulation of myocardial growth factors, up-regulation of nuclear proto-oncogenes, induction of cardiac oxidative stress, as well as activation of mitogen-activated protein kinases and phosphatidylinositol 3-kinase. Sustained β-adrenoreceptor activation contributes to impaired cardiac autonomic regulation as evidenced by blunted parasympathetically-mediated cardiovascular reflexes as well as abnormal storage of myocardial catecholamines. Catecholamine-induced cardiac hypertrophy is associated with reduced contractile responses to adrenergic agonists, an effect attributed to downregulation of myocardial β-adrenoreceptors, uncoupling of β-adrenoreceptors and adenylate cyclase, as well as modifications of downstream cAMP-mediated signaling. In compensated cardiac hypertrophy, these changes are associated with preserved or even enhanced basal ventricular systolic function due to increased sarcoplasmic reticulum Ca2+ content and Ca2+-induced sarcoplasmic reticulum Ca2+ release. The increased availability of Ca2+ to maintain cardiomyocyte contraction is attributed to prolongation of the action potential due to inhibition of the transient outward potassium current as well as stimulation of the reverse mode of the Na+–Ca2+ exchange. Further progression of cardiac hypertrophy towards heart failure is due to abnormalities in Ca2+ handling, necrotic myocardial injury, and increased myocardial stiffness due to interstitial fibrosis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Fitness & Wellness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

google, scholar, cas, pubmed, cardiac, hypertrophy, pharmacol, rat, heart, myocardial, res, isoproterenolinduced, ventricular, physiol, isoproterenol, left, rats, chronic, cardiol, cardiovasc, stimulation, mol, cell, protein, βadrenergic, circ, circulation, norepinephrine, expression, failure, effects, function, regulation, receptor, activation, exp, βadrenoceptor, article, angiotensin, growth, effect, catecholamineinduced, infusion, role, arch, eur, response, myocytes, kinase, cyclase,

Topics {✒️}

triiodo-l-thyronine induce c-fos long-term beta-adrenoceptor-mediated alteration inhibitory g-protein α-subunits month download article/chapter mitogen-activated protein kinases long term β-adrenoceptor-mediated long-term β-adrenergic stimulation β-adrenergic receptor-mediated activation β-adrenoceptor-adenylate cyclase system 5’-monophosphate-dependent protein kinase camp-dependent protein kinase beta-adrenoceptor signalling pathway ras/raf/erk signaling beta-blocker therapy influences downstream camp-mediated signaling stimulatory g-protein gsα adrenoreceptor-induced cardiac hypertrophy sustained β-adrenoreceptor activation skeletal α-actin gene angiotensin i-converting enzyme β-adrenergic-induced beating cardiac β-adrenergic receptors cardiac β-adrenoceptor subtypes adrenergic-induced cardiac hypertrophy β-adrenergic cardiac hypertrophy chronic β-adrenoreceptor stimulation β-adrenergic receptor stimulation β-adrenoceptor-mediated hypertrophy cardiac beta-adrenoceptor system catecholamine-induced cardiac hypertrophy drug-induced cardiac enlargement chronic β-adrenoreceptor activation β-adrenoceptor-mediated release α-adrenoceptor-mediated responses catecholamine-induced myocardial hypertrophy aldosterone-induced cardiac fibrosis β2-receptor-mediated responses guinea-pig sinoatrial node sarcoplasmic reticulum ca++-atpase isoproterenol-induced cardiac hypertrophy cardiac renin-angiotensin system k-atpase α-subunit noradrenaline-treated guinea-pigs chronic β-adrenoceptor stimulation chronic beta-adrenergic stimulation isoproterenol-induced myocardial necrosis isoproterenol-induced myocardial fibrosis isoprenaline-induced cardiac hypertrophy isoproterenol-induced myocardial infarction β-adrenergic agonists stimulate

Questions {❓}

Goldspink DF, Burniston JG, Ellison GM et al (2004) Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?
Katz AM (1990) Angiotensin II: hemodynamic regulator or growth factor?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects
         description:Cardiac hypertrophy is promoted by adrenergic over-activation and represents an independent risk factor for cardiovascular morbidity and mortality. The basic knowledge about mechanisms by which sustained adrenergic activation promotes myocardial growth, as well as understanding how structural changes in hypertrophied myocardium could affect myocardial function has been acquired from studies using an animal model of chronic systemic β-adrenoreceptor agonist administration. Sustained β-adrenoreceptor activation was shown to enhance the synthesis of myocardial proteins, an effect mediated via stimulation of myocardial growth factors, up-regulation of nuclear proto-oncogenes, induction of cardiac oxidative stress, as well as activation of mitogen-activated protein kinases and phosphatidylinositol 3-kinase. Sustained β-adrenoreceptor activation contributes to impaired cardiac autonomic regulation as evidenced by blunted parasympathetically-mediated cardiovascular reflexes as well as abnormal storage of myocardial catecholamines. Catecholamine-induced cardiac hypertrophy is associated with reduced contractile responses to adrenergic agonists, an effect attributed to downregulation of myocardial β-adrenoreceptors, uncoupling of β-adrenoreceptors and adenylate cyclase, as well as modifications of downstream cAMP-mediated signaling. In compensated cardiac hypertrophy, these changes are associated with preserved or even enhanced basal ventricular systolic function due to increased sarcoplasmic reticulum Ca2+ content and Ca2+-induced sarcoplasmic reticulum Ca2+ release. The increased availability of Ca2+ to maintain cardiomyocyte contraction is attributed to prolongation of the action potential due to inhibition of the transient outward potassium current as well as stimulation of the reverse mode of the Na+–Ca2+ exchange. Further progression of cardiac hypertrophy towards heart failure is due to abnormalities in Ca2+ handling, necrotic myocardial injury, and increased myocardial stiffness due to interstitial fibrosis.
         datePublished:2007-03-27T00:00:00Z
         dateModified:2007-03-27T00:00:00Z
         pageStart:66
         pageEnd:86
         sameAs:https://doi.org/10.1007/s10741-007-9007-4
         keywords:
            Catecholamines
            Cardiac hypertrophy
            β-adrenoreceptor
            Ventricular systolic function
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-007-9007-4/MediaObjects/10741_2007_9007_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-007-9007-4/MediaObjects/10741_2007_9007_Fig2_HTML.gif
         isPartOf:
            name:Heart Failure Reviews
            issn:
               1573-7322
               1382-4147
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers-Plenum Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Oleg E. Osadchii
               affiliation:
                     name:University of Liverpool
                     address:
                        name:Cardiology Group, School of Clinical Sciences, University Clinical Departments, University of Liverpool, Liverpool, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects
      description:Cardiac hypertrophy is promoted by adrenergic over-activation and represents an independent risk factor for cardiovascular morbidity and mortality. The basic knowledge about mechanisms by which sustained adrenergic activation promotes myocardial growth, as well as understanding how structural changes in hypertrophied myocardium could affect myocardial function has been acquired from studies using an animal model of chronic systemic β-adrenoreceptor agonist administration. Sustained β-adrenoreceptor activation was shown to enhance the synthesis of myocardial proteins, an effect mediated via stimulation of myocardial growth factors, up-regulation of nuclear proto-oncogenes, induction of cardiac oxidative stress, as well as activation of mitogen-activated protein kinases and phosphatidylinositol 3-kinase. Sustained β-adrenoreceptor activation contributes to impaired cardiac autonomic regulation as evidenced by blunted parasympathetically-mediated cardiovascular reflexes as well as abnormal storage of myocardial catecholamines. Catecholamine-induced cardiac hypertrophy is associated with reduced contractile responses to adrenergic agonists, an effect attributed to downregulation of myocardial β-adrenoreceptors, uncoupling of β-adrenoreceptors and adenylate cyclase, as well as modifications of downstream cAMP-mediated signaling. In compensated cardiac hypertrophy, these changes are associated with preserved or even enhanced basal ventricular systolic function due to increased sarcoplasmic reticulum Ca2+ content and Ca2+-induced sarcoplasmic reticulum Ca2+ release. The increased availability of Ca2+ to maintain cardiomyocyte contraction is attributed to prolongation of the action potential due to inhibition of the transient outward potassium current as well as stimulation of the reverse mode of the Na+–Ca2+ exchange. Further progression of cardiac hypertrophy towards heart failure is due to abnormalities in Ca2+ handling, necrotic myocardial injury, and increased myocardial stiffness due to interstitial fibrosis.
      datePublished:2007-03-27T00:00:00Z
      dateModified:2007-03-27T00:00:00Z
      pageStart:66
      pageEnd:86
      sameAs:https://doi.org/10.1007/s10741-007-9007-4
      keywords:
         Catecholamines
         Cardiac hypertrophy
         β-adrenoreceptor
         Ventricular systolic function
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-007-9007-4/MediaObjects/10741_2007_9007_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-007-9007-4/MediaObjects/10741_2007_9007_Fig2_HTML.gif
      isPartOf:
         name:Heart Failure Reviews
         issn:
            1573-7322
            1382-4147
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers-Plenum Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Oleg E. Osadchii
            affiliation:
                  name:University of Liverpool
                  address:
                     name:Cardiology Group, School of Clinical Sciences, University Clinical Departments, University of Liverpool, Liverpool, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Heart Failure Reviews
      issn:
         1573-7322
         1382-4147
      volumeNumber:12
Organization:
      name:Kluwer Academic Publishers-Plenum Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Liverpool
      address:
         name:Cardiology Group, School of Clinical Sciences, University Clinical Departments, University of Liverpool, Liverpool, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Oleg E. Osadchii
      affiliation:
            name:University of Liverpool
            address:
               name:Cardiology Group, School of Clinical Sciences, University Clinical Departments, University of Liverpool, Liverpool, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cardiology Group, School of Clinical Sciences, University Clinical Departments, University of Liverpool, Liverpool, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(509)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.41s.

LINK . SPRINGER . COM {}